Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph.

BMC bioinformatics·2026
Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026
Same author

Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real-Life National Setting Over a Decade.

Cancer medicine·2026
Same author

NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

Molecular cancer therapeutics·2026
Same author

TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies.

Molecular cancer therapeutics·2026
Same author

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Cancers·2026

Related Experiment Video

Updated: Jul 3, 2026

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
10:12

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues

Published on: January 10, 2019

Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data.

Fathi Elloumi1, Camille Tlemsani2, Christine M Heske3

  • 1Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

STAR Protocols
|September 26, 2025
PubMed
Summary

This study details setting up CellMiner Cross-Database (CellMinerCDB), an application for cancer cell line data analysis. The protocol enables molecular and pharmacological data integration and analysis for cancer research.

Keywords:
BioinformaticsCancerGenomicsHealth Sciences

More Related Videos

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
09:55

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

Targeted Metabolomics on Rare Primary Cells
08:28

Targeted Metabolomics on Rare Primary Cells

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jul 3, 2026

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues
10:12

Droplet Barcoding-Based Single Cell Transcriptomics of Adult Mammalian Tissues

Published on: January 10, 2019

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
09:55

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

Targeted Metabolomics on Rare Primary Cells
08:28

Targeted Metabolomics on Rare Primary Cells

Published on: February 23, 2024

Area of Science:

  • Bioinformatics
  • Genomics
  • Pharmacology

Background:

  • Cancer cell line data integration is crucial for research.
  • Analyzing molecular and pharmacological profiles aids drug discovery.
  • Existing tools may lack comprehensive cross-database analysis capabilities.

Purpose of the Study:

  • To provide a detailed protocol for setting up CellMiner Cross-Database (CellMinerCDB).
  • To enable integrated analysis of molecular and pharmacological data across human cancer cell lines.
  • To demonstrate the application using sarcoma data.

Main Methods:

  • Software installation and configuration.
  • Preparation of compatible molecular and pharmacological datasets.
  • Deployment of the CellMinerCDB application for data analysis.

Main Results:

  • A functional CellMinerCDB setup enabling data integration.
  • Successful demonstration of univariate and multivariate analyses.
  • Customizable configuration for diverse cancer datasets.

Conclusions:

  • CellMinerCDB provides a robust platform for cross-database cancer cell line analysis.
  • The detailed protocol facilitates the implementation of this powerful analytical tool.
  • This facilitates deeper insights into cancer biology and therapeutic strategies.